<SEC-DOCUMENT>0001965301-24-000135.txt : 20241021
<SEC-HEADER>0001965301-24-000135.hdr.sgml : 20241021
<ACCEPTANCE-DATETIME>20241021164554
ACCESSION NUMBER:		0001965301-24-000135
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241021
DATE AS OF CHANGE:		20241021

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Roivant Sciences Ltd.
		CENTRAL INDEX KEY:			0001635088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				981173944
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40782
		FILM NUMBER:		241383920

	BUSINESS ADDRESS:	
		STREET 1:		CLARENDON HOUSE, 2 CHURCH STREET
		CITY:			HAMILTON HM11
		STATE:			D0
		ZIP:			HM11
		BUSINESS PHONE:		441-295-5950

	MAIL ADDRESS:	
		STREET 1:		CLARENDON HOUSE
		STREET 2:		2 CHURCH STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM11

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Venker Eric
		CENTRAL INDEX KEY:			0001801917
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O ROIVANT SCIENCES, INC.
		STREET 2:		320 WEST 37TH STREET, 6TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001801917</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001635088</issuerCik>
      <issuerName>Roivant Sciences Ltd.</issuerName>
      <secFileNumber>001-40782</secFileNumber>
      <issuerAddress>
        <com:street1>CLARENDON HOUSE, 2 CHURCH STREET</com:street1>
        <com:city>HAMILTON HM11</com:city>
        <com:stateOrCountry>D0</com:stateOrCountry>
        <com:zipCode>HM11</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>441-295-5950</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Venker Eric</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Rockefeller Financial LLC</name>
        <address>
          <com:street1>45 Rockefeller Plaza</com:street1>
          <com:street2>Floor 5</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10111</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>100000</noOfUnitsSold>
      <aggregateMarketValue>1165393.15</aggregateMarketValue>
      <noOfUnitsOutstanding>739521824</noOfUnitsOutstanding>
      <approxSaleDate>10/21/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <acquiredDate>10/21/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Options Exercise - Grant Date 4/20/2022 </natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>100000</amountOfSecuritiesAcquired>
      <paymentDate>10/21/2024</paymentDate>
      <natureOfPayment>Wire</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/25/2024.</remarks>
    <noticeSignature>
      <noticeDate>10/21/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>06/25/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Eric Venker</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
